These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10999746)

  • 61. A life-long search for the molecular pathways of steroid hormone action.
    O'Malley BW
    Mol Endocrinol; 2005 Jun; 19(6):1402-11. PubMed ID: 15914709
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Estrogen-receptor protein in intracranial meningiomas.
    Donnell MS; Meyer GA; Donegan WL
    J Neurosurg; 1979 Apr; 50(4):499-502. PubMed ID: 423006
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Steroid receptor coactivator-3 as a potential molecular target for cancer therapy.
    Tien JC; Xu J
    Expert Opin Ther Targets; 2012 Nov; 16(11):1085-96. PubMed ID: 22924430
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The round ligament: a target organ for steroid hormones.
    Smith P; Heimer G; Norgren A; Ulmsten U
    Gynecol Endocrinol; 1993 Jun; 7(2):97-100. PubMed ID: 8213233
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Estrogen receptor variants mRNA in human meningiomas.
    Koehorst SG; Jacobs HM; Thijssen JH; Blankenstein MA
    Ann N Y Acad Sci; 1993 Jun; 684():222-3. PubMed ID: 8317837
    [No Abstract]   [Full Text] [Related]  

  • 66. [Histochemical characterization of lipids in meningiomas and their comparison with neurinomas].
    Codegone ML; Peres B; Schiffer D
    Acta Neurol (Napoli); 1970; 25(5):532-4. PubMed ID: 5491152
    [No Abstract]   [Full Text] [Related]  

  • 67. Imbalanced expression pattern of steroid receptor coactivator-1 and -3 in liver cancer compared with normal liver: An immunohistochemical study with tissue microarray.
    Li S; Zhang H; Yu Y; Liu M; Guo D; Zhang X; Zhang J
    Oncol Lett; 2018 Nov; 16(5):6339-6348. PubMed ID: 30405769
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Regression of Multiple Meningiomas after Discontinuation of Chronic Hormone Therapy: A Case Report.
    Shahin MN; Bowden SG; Yaghi NK; Bagley JH; Han SJ; Varlamov EV; Grafe MR; Cetas JS
    J Neurol Surg Rep; 2021 Oct; 82(4):e38-e42. PubMed ID: 34877245
    [No Abstract]   [Full Text] [Related]  

  • 69. Isolation and characterisation of glycolipids and glycosaminoglycans from meningiomas.
    Aruna RM; Balasubramanian KA; Mathai KV; Basu D
    Indian J Med Res; 1973 Nov; 61(11):1688-93. PubMed ID: 4275526
    [No Abstract]   [Full Text] [Related]  

  • 70. Diagnosis, Treatment, and Management Strategy of Meningioma during Pregnancy.
    Gurcay AG; Bozkurt I; Senturk S; Kazanci A; Gurcan O; Turkoglu OF; Beskonakli E
    Asian J Neurosurg; 2018; 13(1):86-89. PubMed ID: 29492130
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Progesterone and meningiomas.
    Davis C
    J Neurosurg; 2011 Feb; 114(2):561; author reply 561. PubMed ID: 21128740
    [No Abstract]   [Full Text] [Related]  

  • 72. Letter: Brain Invasion in Meningiomas-Sex-Associated Differences are not Related to Estrogen- and Progesterone Receptor Expression.
    Heß K; Spille DC; Wagner A; Stummer W; Paulus W; Brokinkel B
    Neurosurgery; 2017 Aug; 81(2):E25-E27. PubMed ID: 28383708
    [No Abstract]   [Full Text] [Related]  

  • 73. Corrigendum to "Novel role of signal transducer and activator of transcription 3 as a progesterone receptor coactivator in breast cancer" [Steroids 76 (2011) 381-392].
    Proietti CJ; Béguelin W; Díaz Flaqué MC; Cayrol F; Rivas MA; Tkach M; Charreau EH; Schillaci R; Elizalde PV
    Steroids; 2023 Dec; 200():109312. PubMed ID: 37788521
    [No Abstract]   [Full Text] [Related]  

  • 74. Nuclear vs translocating steroid receptor models and the excluded middle.
    Welshons WV; Judy BM
    Endocrine; 1995 Jan; 3(1):1-4. PubMed ID: 21153229
    [No Abstract]   [Full Text] [Related]  

  • 75. Progesterone and estrogen receptors: opposing prognostic indicators in meningiomas.
    Pravdenkova S; Al-Mefty O; Sawyer J; Husain M
    J Neurosurg; 2006 Aug; 105(2):163-73. PubMed ID: 17219818
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Progesterone receptor isoform expression in human meningiomas.
    Verheijen FM; Sprong M; Jacobs HM; Donker GH; Amelink GJ; Thijssen JH; Blankenstein MA
    Eur J Cancer; 2001 Aug; 37(12):1488-95. PubMed ID: 11506955
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Dopamine D1, dopamine D2, and prolactin receptor messenger ribonucleic acid expression by the polymerase chain reaction in human meningiomas.
    Carroll RS; Schrell UM; Zhang J; Dashner K; Nomikos P; Fahlbusch R; Black PM
    Neurosurgery; 1996 Feb; 38(2):367-75. PubMed ID: 8869066
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The multifaceted therapeutic value of targeting steroid receptor coactivator-1 in tumorigenesis.
    Chen Q; Guo P; Hong Y; Mo P; Yu C
    Cell Biosci; 2024 Mar; 14(1):41. PubMed ID: 38553750
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Hormone Receptor Expression in Meningiomas: A Systematic Review.
    Agopiantz M; Carnot M; Denis C; Martin E; Gauchotte G
    Cancers (Basel); 2023 Feb; 15(3):. PubMed ID: 36765937
    [TBL] [Abstract][Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.